King of Prussia, PA, United States of America

Brent Dorr

This inventor holds 2 USPTO granted patents. Top assignee: Codexis, Inc.. Active years: 2021-2025.


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Brent Dorr: Innovator in Carboxyesterase Enzymes

Introduction

Brent Dorr is a notable inventor based in King of Prussia, PA (US). He has made significant contributions to the field of biochemistry, particularly in the development of engineered carboxyesterase enzymes. With a total of 2 patents, his work has implications for various applications in chemical reactions.

Latest Patents

Brent Dorr's latest patents focus on carboxyesterase polypeptides for amide coupling. The inventions provide engineered carboxyesterase enzymes that exhibit improved properties compared to naturally occurring wild-type carboxyesterase enzymes. These patents also include polynucleotides encoding the engineered enzymes, host cells capable of expressing them, and methods for utilizing these enzymes in amidation reactions.

Career Highlights

Brent Dorr is currently associated with Codexis, Inc., where he continues to innovate in the field of enzyme engineering. His work has been instrumental in advancing the understanding and application of carboxyesterase enzymes in various industrial processes.

Collaborations

Brent has collaborated with notable colleagues such as Douglas E Fuerst and David Entwistle, contributing to a dynamic research environment that fosters innovation and development.

Conclusion

Brent Dorr's contributions to the field of biochemistry through his patents on engineered carboxyesterase enzymes highlight his role as a significant inventor. His work not only advances scientific knowledge but also has practical applications in various industries.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…